Mahagaba NT 75mg/10mg Tablet is a combination medication containing Pregabalin 75mg and Nortriptyline 10mg, indicated for the management of neuropathic pain and certain mood disorders. Pregabalin, a gamma-aminobutyric acid (GABA) analogue, acts by modulating calcium channels in the central nervous system, thereby reducing neurotransmitter release and alleviating neuropathic pain symptoms. Nortriptyline, a tricyclic antidepressant, inhibits the reuptake of norepinephrine and serotonin, enhancing mood and providing additional analgesic effects. This synergistic combination is particularly effective in patients with chronic neuropathic pain conditions such as diabetic neuropathy, postherpetic neuralgia, and fibromyalgia, where both pain relief and mood stabilization are required. Mahagaba NT is administered orally, with dosing individualized based on clinical response and tolerability. Common adverse effects may include dizziness, somnolence, dry mouth, and gastrointestinal disturbances; caution is advised in patients with a history of cardiac disorders, glaucoma, or urinary retention. Regular monitoring is recommended to assess therapeutic efficacy and detect potential side effects. Mahagaba NT should be used under strict medical supervision, especially in patients with concomitant medications or comorbidities, to optimize treatment outcomes and minimize risks.